The global continuous bladder irrigation devices market size was valued at USD 1.29 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2030. The growth of the market is due to various factors such as an increase in the number of bladder and prostate surgeries, increasing incidence of urological disorders, such as urinary tract infections, bladder cancer, and kidney stones, rising government initiatives globally, development of more efficient and user-friendly devices, and a rise in the geriatric population. According to NIH, in August 2022, after the age of 60, the prevalence of benign prostatic hyperplasia (BPH) in men will rise 50% to 60 %, and after the age of 70s, it will be rise up to 80% to 90%.
The market growth is anticipated to be fueled by the increasing efforts of various private entities and nonprofit organizations to raise awareness about continuous bladder irrigation devices on a global scale. For example, in January 2021, the Australian Government launched the Incontinence AIDS Payment Scheme to provide support for individuals grappling with persistent or severe incontinence problems. Furthermore, the Australian Government has implemented the National Incontinence Control Program with the aim of enhancing awareness regarding bladder and bowel health issues. Various experts, including urologists, physiotherapists, gynecologists, nurses, general practitioners, and professional associations, actively participate in promoting continence awareness across all realms of healthcare.
In addition to the factors mentioned above, the global market is experiencing consolidation owing to the increasing popularity of medical equipment and the growing prevalence of research collaborations and agreements among various manufacturers. For instance, in March 2023, Convatec Group Plc recently revealed the commencement of a fresh three-year partnership with Partners in Health (PIH), an organization dedicated to establishing fair and accessible healthcare systems in communities that require them most urgently. This collaborative effort initially focuses on enhancing healthcare access for underserved populations in Mexico, Peru, and the U.S, with a goal of positively influencing the lives of 250,000 individuals. Thus, due to such initiatives, the demand for continuous bladder irrigation devices will increase in near future.
For instance, in February 2021, Olympus acquired Medi-Tate to strengthen its business portfolio in the field of in-office treatment for benign prostatic hyperplasia (BPH). Olympus exercised its option to acquire Medi-Tate during the same month. This strategic acquisition is expected to significantly enhance Olympus' position in the urological devices segment, which is expected to boost market growth in the near future.
Moreover, continuous bladder irrigation devices are increasingly seen as a cost-effective and efficient treatment option for various urological conditions. Their ability to manage bladder-related emergencies during surgical procedures makes them indispensable in healthcare settings, contributing to market growth.
In 2022, the foley (3 Way) catheters segment dominated the continuous bladder irrigation devices with a market share of around 56.40%. This growth can be anticipated due to rise in cases of bladder tumor resection, benign prostatic hyperplasia (BPH), and hematuria. According to NIH, in August 2022, around 50% of patients from the emergency department were facing hematuria.Increasing prevalence of urological disorders such as urinary tract infections (UTIs), prostate cancer, bladder cancer will further increase the demand for foley (3-way) catheters and contribute to the segment growth.
Whereas the accessories segment is expected to grow at the highest compound annual growth rate of 5.10% (CAGR) from 2023 to 2030. The accessories segment includes irrigation sets, roller clamps, outlet bags, clips, and bulbs. These accessories help in the maintenance of catheter patency, help in prevention of blood clots and minimize the infection risk. Furthermore, continuous bladder irrigation(CBI) accessories assist healthcare providers in controlling the flow rate and volume of sterile solution being infused into the bladder and therefore, contribute to a streamlined healthcare workflow. Thus, the benefits associated with accessories are expected to boost segment growth over the forecast period.
The hospital segment held the largest share of 53.14% in the market for continuous bladder irrigation devices in 2022. The growth of this segment can be primarily attributed to the rising number of patients experiencing various urological conditions. This, in turn, has led to an upsurge in surgical interventions. Hospitals experience a significantly greater influx of patients seeking urological procedures and other treatments compared to other healthcare settings. This can be attributed to the ease of managing any unforeseen emergencies that may arise during surgical procedures, as well as the availability of a diverse range of treatment options. Consequently, it is expected that the hospitals segment will be positively influenced by these factors.
The long-term care facilities segment is expected to grow at the highest compound annual growth rate over the forecast period. Long-term care facilities plays an important role in the management of continuous bladder irrigation (CBI) and focus on maintaining hygiene and seeking appropriate medical assistance when needed. Long-term care facilities can offer a controlled environment with a lower risk of exposure to hospital-acquired infections, which is especially beneficial for residents using CBI devices. As a result of the factors discussed above, long-term care facilities segment is expected to rise rapidly over the forecast period.
North America dominated the continuous bladder irrigation devices regional market in 2022 with the largest share of around 31.83% by revenue. In North America urology is a well-established medical field with a significant number of medical professionals specializing in it. The developed healthcare systems in North America nations provide a wide range of urological services, such as diagnosis, therapy, and operations. Various initiatives in the field of urology in countries such as the U.S. and Canada are contributing to the growth of the regional market. For instance, in September 2023, The Urology Foundation launched a program titled "Urology Awareness Month 2023." This program aims to bring together the urology community, including researchers, urologists, nurses, other healthcare professionals, decision-makers, influencers, patients, and their families, for a significant initiative aimed at promoting awareness of urological disorders.
Asia Pacific is expected to grow at the highest compound annual growth rate (CAGR) from 2023 to 2030. Rising prevalence of benign prostatic hyperplasia (BPH) and urinary tract infection (UTI) in Asia Pacific region is expected to boost demand for continuous bladder irrigation devices in this region. For instance, in November 2022, China has the highest number of Benign Prostatic Hyperplasia (BPH) clinical trials. Additionally, there is a high need for colostomies in nations like China and India, where many people have bladder problems. Most geriatric people are more likely to develop stomas and undergo ileostomy and colostomy procedures. As a result, the demand for CBI care products and accessories in Asia Pacific is expanding because of the rising geriatric population as well as the rising number of people with bladder diseases.
The competitors in the market are enforcing higher product quality through mergers and acquisitions to gain a larger share of the market. For instance, in July 2023, Teleflex acquire Palette Life Sciences for USD 600 million to expand their urology portfolio, with the acquisition of Palette Life Sciences, Teleflex will be able to add the latest technology to its interventional urology business line, giving urologists, radiation oncologists, and other specialists access to more cutting-edge tools that will improve patient care. For instance, in October 2022, Hollister Incorporated published a study on patient support programs through the Journal of Wound Ostomy & Continence Nursing (JWOCN). This study focuses on connecting support service interactions to offer enhanced results in areas of skin health, stoma barrier leakage, and proper fit. Thus, due to such factors, the demand for continuous bladder irrigation devices will increase in the near future. Some prominent players in the global continuous bladder irrigation devices market include:
Sterimed Group.
Angiplast pvt. ltd.
Advin Health Care
AdvaCare Pharma
Teleflex Incorporated
BACTIGUARD AB
VOGT MEDICAL
C. R. Bard (BD)
Coloplast
HEMC (Hospital Equipment Manufacturing Company)
Baxter Internationals
Report Attribute |
Details |
Market size value in 2023 |
USD 1.35 billion |
Revenue forecast in 2030 |
USD 1.87 billion |
Growth rate |
CAGR of 4.7% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million, and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S., Canada, UK, Germany, France, Italy, Spain, Norway, Sweden, Denmark, Japan, China, India, Australia, Thailand, South Korea, Brazil, Mexico, Colombia, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
Sterimed Group.; Angiplast Pvt. Ltd.; Advin Health Care; Advacare Pharma; Teleflex Incorporated; Bactiguard Ab; Vogt Medical; C. R. Bard (Bd); Coloplast; HEMC (Hospital Equipment Manufacturing Company); Baxter Internationals. |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global continuous bladder irrigation devices market report on the basis of product, end-use,and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Foley 3-way Catheters
Silicon Catheters
Latex Catheters
Accessories
Irrigation Set
Roller Clamp
Outlet Bags
Irrigation Bags
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Long Term Care Facilities
Hospitals
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
b. The global continuous bladder irrigation devices market size was estimated at USD 1.29 billion in 2022 and is expected to reach USD 1.35 billion in 2023.
b. The global continuous bladder irrigation devices market is expected to grow at a compound annual growth rate of 4.7% from 2023 to 2030 to reach USD 1.87 billion by 2030.
b. The Foley 3-way catheters segment dominated the market in 2022 with a share of 54.40%. This growth can be attributed due to the three-way catheters can lead to cost savings in the long run and reducing the need for additional equipment and supplies related to irrigation.
b. Key players in the continuous bladder irrigation devices market include Sterimed Group., Angiplast Pvt. Ltd., Advin Health Care, Advacare Pharma, Teleflex Incorporated, Bactiguard Ab, Vogt Medical, C. R. Bard (Bd), Coloplast, HEME (Hospital Equipment Manufacturing Company), Baxter Internationals.
b. The factors responsible for the continuous bladder irrigation devices market growth are an increase in the number of transurethral resections of the prostate (TURP) surgeries globally, a rise in the geriatric population, technological advancements, and increasing prevalence of urological disorders such as urinary tract infections (UTIs), prostate cancer, bladder cancer, and others.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."